UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging

Journal of internal medicine, 2015-05, Vol.277 (5), p.605-614

2015

Volltextzugriff (PDF)

Cardiogenic shock and acute kidney injury: the rule rather than the exception

Heart failure reviews, 2021-05, Vol.26 (3), p.487-496

2021

Volltextzugriff (PDF)

Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images

Journal of nuclear cardiology, 2022-08, Vol.29 (4), p.1919-1932

2022

Volltextzugriff (PDF)

The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences

Heart failure reviews, 2022-07, Vol.27 (4), p.1235-1246

2022

Volltextzugriff (PDF)

CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy

Europace (London, England), 2014-01, Vol.16 (1), p.71-80

2014

Volltextzugriff (PDF)

Therapies for cardiac light chain amyloidosis: An update

International journal of cardiology, 2018-11, Vol.271, p.152-160

2018

Volltextzugriff (PDF)

Cardiac sympathetic denervation in wild-type transthyretin amyloidosis

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Sacubitril/valsartan improves ventilation stability in patients with chronic heart failure

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Cardiac involvement in creatine deficiency syndrome

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Assessment of repolarization dispersion by using endocardial unipolar electrograms in patients with brugada syndrome and spontaneous coved-type electrocardiographic pattern

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

C61 RAREFACTION OF MYOCARDIAL LYMPHATIC VESSELS IN PATIENTS WITH CARDIAC AMYLOIDOSIS

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D26-D26

2023

Volltextzugriff (PDF)

Reverse remodelling, changes in diastolic function and their prognostic value compared to natriuretic peptides

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

P203 PLASMA TRANSTHYRETIN FORMS IN PATIENTS WITH WILD–TYPE TRANSTHYRETIN CARDIAC AMYLOIDOSIS: INFLUENCED OF TAFAMIDIS TREATMENT

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D117-D117

2023

Volltextzugriff (PDF)

Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

P363 HIGH–SENSITIVITY TROPONINS FOR OUTCOME PREDICTION IN THE GENERAL POPULATION: A SYSTEMATIC REVIEW AND META–ANALYSIS

European heart journal supplements, 2022-05, Vol.24 (Supplement_C)

2022

Volltextzugriff (PDF)

Valve disease in cardiac amyloidosis: an echocardiographic score

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Prevalence of amyloid transthyretin cardiomyopathy in elderly subjects from the general population: first results from the CATCH study

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

P292 REDEFINING THE EPIDEMIOLOGY OF CARDIAC AMYLOIDOSIS. A SYSTEMATIC REVIEW OF SCREENING STUDIES

European heart journal supplements, 2022-05, Vol.24 (Supplement_C)

2022

Volltextzugriff (PDF)

Two common echocardiographic variables to diagnose cardiac amyloidosis: the AMYLoidosis Index (AMYLI) score

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

High-sensitivity cardiac troponin T and NT-proBNP for ruling-in and ruling-out of cardiac amyloidosis

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Reverse remodelling criteria to predict cardiovascular death in heart failure with reduced or mid-range ejection fraction

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Prognostic value of sST2 in heart failure patients with diabetes

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(84)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging

Cardiogenic shock and acute kidney injury: the rule rather than the exception

Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images

The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences

CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy

Therapies for cardiac light chain amyloidosis: An update

Cardiac sympathetic denervation in wild-type transthyretin amyloidosis

Sacubitril/valsartan improves ventilation stability in patients with chronic heart failure

Cardiac involvement in creatine deficiency syndrome

Assessment of repolarization dispersion by using endocardial unipolar electrograms in patients with brugada syndrome and spontaneous coved-type electrocardiographic pattern

C61 RAREFACTION OF MYOCARDIAL LYMPHATIC VESSELS IN PATIENTS WITH CARDIAC AMYLOIDOSIS

Reverse remodelling, changes in diastolic function and their prognostic value compared to natriuretic peptides

P203 PLASMA TRANSTHYRETIN FORMS IN PATIENTS WITH WILD–TYPE TRANSTHYRETIN CARDIAC AMYLOIDOSIS: INFLUENCED OF TAFAMIDIS TREATMENT

Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure

Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis

P363 HIGH–SENSITIVITY TROPONINS FOR OUTCOME PREDICTION IN THE GENERAL POPULATION: A SYSTEMATIC REVIEW AND META–ANALYSIS

Valve disease in cardiac amyloidosis: an echocardiographic score

Prevalence of amyloid transthyretin cardiomyopathy in elderly subjects from the general population: first results from the CATCH study

P292 REDEFINING THE EPIDEMIOLOGY OF CARDIAC AMYLOIDOSIS. A SYSTEMATIC REVIEW OF SCREENING STUDIES

Two common echocardiographic variables to diagnose cardiac amyloidosis: the AMYLoidosis Index (AMYLI) score

Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis

High-sensitivity cardiac troponin T and NT-proBNP for ruling-in and ruling-out of cardiac amyloidosis

Reverse remodelling criteria to predict cardiovascular death in heart failure with reduced or mid-range ejection fraction

Prognostic value of sST2 in heart failure patients with diabetes

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

Suchergebnisse filtern